• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prediction of outcome from community-acquired severe sepsis and septic shock in tertiary-care university hospital in a developing country.发展中国家一所三级医疗大学医院中社区获得性严重脓毒症和脓毒性休克的预后预测
Crit Care Res Pract. 2012;2012:182324. doi: 10.1155/2012/182324. Epub 2012 Oct 17.
2
Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock.社区获得性血流感染严重脓毒症和感染性休克患者的死亡率预测因素。
J Crit Care. 2010 Jun;25(2):276-81. doi: 10.1016/j.jcrc.2009.12.004. Epub 2010 Feb 10.
3
Early prognosis in patients with community-acquired severe sepsis and septic shock: analysis of 184 consecutive cases.社区获得性严重脓毒症和脓毒性休克患者的早期预后:184例连续病例分析
Prilozi. 2012;33(2):105-16.
4
Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in Korea.韩国 12 所大学医院开展的一项前瞻性观察性研究:社区获得性严重脓毒症和脓毒性休克的流行病学和临床特征。
J Korean Med Sci. 2012 Nov;27(11):1308-14. doi: 10.3346/jkms.2012.27.11.1308. Epub 2012 Oct 30.
5
[Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].[血清乳酸、降钙素原及严重程度评分对脓毒症休克患者短期预后的联合预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):281-285. doi: 10.3760/cma.j.cn121430-20201113-00715.
6
[Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis].[乳酸、乳酸清除率及降钙素原在评估脓毒症严重程度及预测预后中的作用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):449-453. doi: 10.3760/cma.j.cn121430-20200129-00086.
7
Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.成人严重脓毒症和脓毒性休克的发病率、危险因素及转归。一项在重症监护病房开展的多中心前瞻性研究。法国重症监护病房严重脓毒症研究组
JAMA. 1995 Sep 27;274(12):968-74.
8
[The incidences of organ dysfunction in the early resuscitation of severe sepsis and septic shock patients:a retrospective analysis].[严重脓毒症和脓毒性休克患者早期复苏中器官功能障碍的发生率:一项回顾性分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 May;28(5):418-22.
9
The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.可溶性血栓调节蛋白在急诊科脓毒症患者危险分层和预后评估中的作用。
Thromb Res. 2013 Oct;132(4):471-6. doi: 10.1016/j.thromres.2013.08.011. Epub 2013 Aug 28.
10
A Prospective Study of Comparison of APACHE-IV & SAPS-II Scoring Systems and Calculation of Standardised Mortality Rate in Severe Sepsis and Septic Shock Patients.一项关于急性生理学与慢性健康状况评分系统IV(APACHE-IV)和简化急性生理学评分系统II(SAPS-II)在严重脓毒症和脓毒性休克患者中的比较及标准化死亡率计算的前瞻性研究。
J Clin Diagn Res. 2014 Oct;8(10):MC09-13. doi: 10.7860/JCDR/2014/9925.5052. Epub 2014 Oct 20.

引用本文的文献

1
Impact of heart failure on outcomes in patients with sepsis: A systematic review and meta-analysis.心力衰竭对脓毒症患者预后的影响:一项系统评价与荟萃分析。
World J Clin Cases. 2023 May 26;11(15):3511-3521. doi: 10.12998/wjcc.v11.i15.3511.
2
Diagnosis and Management of Bloodstream Infections With Rapid, Multiplexed Molecular Assays.快速、多重分子检测在血流感染中的诊断和管理。
Front Cell Infect Microbiol. 2022 Mar 16;12:859935. doi: 10.3389/fcimb.2022.859935. eCollection 2022.
3
Clinical and microbiological characteristics and outcomes of community-acquired sepsis among adults: a single center, 1-year retrospective observational cohort study from Hungary.成人社区获得性败血症的临床和微生物学特征及转归:来自匈牙利的一项为期 1 年的单中心回顾性观察队列研究。
BMC Infect Dis. 2019 Jul 26;19(1):584. doi: 10.1186/s12879-019-4219-5.
4
Epidemiology of sepsis in Brazil: Incidence, lethality, costs, and other indicators for Brazilian Unified Health System hospitalizations from 2006 to 2015.巴西脓毒症的流行病学:2006 年至 2015 年巴西统一卫生系统住院患者的发病率、死亡率、费用和其他指标。
PLoS One. 2018 Apr 13;13(4):e0195873. doi: 10.1371/journal.pone.0195873. eCollection 2018.
5
The Changing Epidemiology and Definitions of Sepsis.脓毒症不断变化的流行病学及定义
Clin Chest Med. 2016 Jun;37(2):165-79. doi: 10.1016/j.ccm.2016.01.002. Epub 2016 Mar 23.
6
Combined Therapy With Adipose-Derived Mesenchymal Stem Cells and Ciprofloxacin Against Acute Urogenital Organ Damage in Rat Sepsis Syndrome Induced by Intrapelvic Injection of Cecal Bacteria.脂肪来源间充质干细胞与环丙沙星联合治疗对盆腔注射盲肠细菌诱导的大鼠脓毒症综合征急性泌尿生殖器官损伤的影响
Stem Cells Transl Med. 2016 Jun;5(6):782-92. doi: 10.5966/sctm.2015-0116. Epub 2016 Apr 13.
7
Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial.红花黄色素对严重脓毒症和脓毒性休克治疗的影响:一项随机对照临床试验
Evid Based Complement Alternat Med. 2016;2016:3948795. doi: 10.1155/2016/3948795. Epub 2016 Feb 18.
8
Glycyrrhizic Acid Attenuates Sepsis-Induced Acute Kidney Injury by Inhibiting NF-κB Signaling Pathway.甘草酸通过抑制NF-κB信号通路减轻脓毒症诱导的急性肾损伤。
Evid Based Complement Alternat Med. 2016;2016:8219287. doi: 10.1155/2016/8219287. Epub 2016 Jan 24.
9
Risk stratification by abbMEDS and CURB-65 in relation to treatment and clinical disposition of the septic patient at the emergency department: a cohort study.急诊科中,基于abbMEDS和CURB-65对脓毒症患者进行风险分层与治疗及临床处置的相关性:一项队列研究。
BMC Emerg Med. 2015 Oct 13;15:29. doi: 10.1186/s12873-015-0056-z.
10
Performance Evaluation of the Verigene Gram-Positive and Gram-Negative Blood Culture Test for Direct Identification of Bacteria and Their Resistance Determinants from Positive Blood Cultures in Hong Kong.用于直接从香港阳性血培养物中鉴定细菌及其耐药决定因素的Verigene革兰氏阳性和革兰氏阴性血培养检测的性能评估
PLoS One. 2015 Oct 2;10(10):e0139728. doi: 10.1371/journal.pone.0139728. eCollection 2015.

本文引用的文献

1
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.2003 年至 2007 年美国严重脓毒症的住院治疗、费用和结果。
Crit Care Med. 2012 Mar;40(3):754-61. doi: 10.1097/CCM.0b013e318232db65.
2
The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals.哥伦比亚脓毒症的流行病学:十所大学医院的前瞻性多中心队列研究。
Crit Care Med. 2011 Jul;39(7):1675-82. doi: 10.1097/CCM.0b013e318218a35e.
3
Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.严重脓毒症和感染性休克患者的结局:病原体种类和感染部位与死亡率无关。
Crit Care Med. 2011 Aug;39(8):1886-95. doi: 10.1097/CCM.0b013e31821b827c.
4
Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study.通过强化推荐组合降低严重脓毒症或脓毒性休克相关死亡率:一项多中心研究
Ann Fr Anesth Reanim. 2010 Sep;29(9):621-8. doi: 10.1016/j.annfar.2010.04.007. Epub 2010 Jul 14.
5
Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study).通过实施核心 6 小时bundle 降低严重脓毒症的死亡率:来自葡萄牙社区获得性脓毒症研究(SACiUCI 研究)的结果。
Crit Care. 2010;14(3):R83. doi: 10.1186/cc9008. Epub 2010 May 10.
6
Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock.社区获得性血流感染严重脓毒症和感染性休克患者的死亡率预测因素。
J Crit Care. 2010 Jun;25(2):276-81. doi: 10.1016/j.jcrc.2009.12.004. Epub 2010 Feb 10.
7
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.拯救脓毒症运动:以严重脓毒症为目标的基于国际指南的绩效改进计划的结果。
Crit Care Med. 2010 Feb;38(2):367-74. doi: 10.1097/CCM.0b013e3181cb0cdc.
8
International study of the prevalence and outcomes of infection in intensive care units.重症监护病房感染患病率及转归的国际研究。
JAMA. 2009 Dec 2;302(21):2323-9. doi: 10.1001/jama.2009.1754.
9
The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting.一所三级护理大学医院中严重脓毒症和脓毒性休克死亡的流行病学及危险因素。
Epidemiol Infect. 2009 Sep;137(9):1333-41. doi: 10.1017/S0950268809002027. Epub 2009 Feb 4.
10
Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study.严重脓毒症的发病率、器官功能障碍及死亡率:一项西班牙多中心研究
Crit Care. 2008;12(6):R158. doi: 10.1186/cc7157. Epub 2008 Dec 17.

发展中国家一所三级医疗大学医院中社区获得性严重脓毒症和脓毒性休克的预后预测

Prediction of outcome from community-acquired severe sepsis and septic shock in tertiary-care university hospital in a developing country.

作者信息

Grozdanovski Krsto, Milenkovic Zvonko, Demiri Ilir, Spasovska Katerina

机构信息

Department of Intensive Care, University Clinic for Infectious Diseases, Vodnjanska 17, 1000 Skopje, Macedonia.

出版信息

Crit Care Res Pract. 2012;2012:182324. doi: 10.1155/2012/182324. Epub 2012 Oct 17.

DOI:10.1155/2012/182324
PMID:23119151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3483665/
Abstract

Our aim was to determine the risk factors on mortality in adult patients with community-acquired severe sepsis and septic shock. The main outcome measure was hospital mortality. This prospective single centre study was conducted from January 1, 2008 to December 31, 2010, and included 184 patients, of whom 135 (73.4%) were with severe sepsis and 49 (26.6%) had septic shock. Overall, ninety-five (51.6%) patients have died, 60 (44.4%) in severe sepsis and 35 (71.4%) patients with septic shock. The lung was the most common site of infection 121 (65.8%), and chronic heart failure was the most frequent comorbidity 65 (35.3%). Logistic multivariate analysis identified three independent risk factors for mortality in patients with severe sepsis: positive blood culture (odds ratio, 2.39; 95% confidence interval, 1.13-5.06; P = 0.02), three or more organ dysfunctions (odds ratio, 3.93; 95% confidence interval, 1.62-9.53; P = 0.002), and Simplified Acute Physiology Score (SAPS) II (odds ratio, 1.02; 95% confidence interval, 1.00-1.04; P = 0.01). In addition to SAPS II, positive blood culture, and three or more organ dysfunctions are important independent risk factors for mortality in patients with severe sepsis and septic shock.

摘要

我们的目的是确定社区获得性严重脓毒症和脓毒性休克成年患者的死亡风险因素。主要结局指标是医院死亡率。这项前瞻性单中心研究于2008年1月1日至2010年12月31日进行,纳入了184例患者,其中135例(73.4%)为严重脓毒症,49例(26.6%)患有脓毒性休克。总体而言,95例(51.6%)患者死亡,严重脓毒症患者中60例(44.4%)死亡,脓毒性休克患者中35例(71.4%)死亡。肺部是最常见的感染部位121例(65.8%),慢性心力衰竭是最常见的合并症65例(35.3%)。多因素logistic分析确定了严重脓毒症患者死亡的三个独立风险因素:血培养阳性(比值比,2.39;95%置信区间,1.13 - 5.06;P = 0.02)、三个或更多器官功能障碍(比值比,3.93;95%置信区间,1.62 - 9.53;P = 0.002)以及简化急性生理学评分(SAPS)II(比值比,1.02;95%置信区间,1.00 - 1.04;P = 0.01)。除SAPS II外,血培养阳性和三个或更多器官功能障碍是严重脓毒症和脓毒性休克患者死亡的重要独立风险因素。